tiprankstipranks
Lavipharm S.A. (DE:BXA0)
FRANKFURT:BXA0
Germany Market
BXA0
Lavipharm S.A.
RESEARCH TOOLSreports

Lavipharm S.A. (BXA0) Ratios

0 Followers

Lavipharm S.A. Ratios

DE:BXA0's free cash flow for Q4 2025 was €0.48. For the 2025 fiscal year, DE:BXA0's free cash flow was decreased by € and operating cash flow was €-0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.21 1.21 1.15 1.28 1.00
Quick Ratio
 0.68 0.68 0.62 0.86 0.76
Cash Ratio
 0.14 0.14 0.14 0.24 0.40
Solvency Ratio
 0.15 0.15 0.19 0.08 0.03
Operating Cash Flow Ratio
 0.15 0.15 0.12 0.02 0.07
Short-Term Operating Cash Flow Coverage
 0.89 0.89 0.45 0.07 0.16
Net Current Asset Value
€ -21.07M€ -21.07M€ -27.71M€ -26.42M€ -28.44M
Leverage Ratios
Debt-to-Assets Ratio
 0.22 0.22 0.27 0.28 0.32
Debt-to-Equity Ratio
 0.50 0.50 0.64 0.76 0.92
Debt-to-Capital Ratio
 0.33 0.33 0.39 0.43 0.48
Long-Term Debt-to-Capital Ratio
 0.15 0.15 0.19 0.23 0.09
Financial Leverage Ratio
 2.32 2.32 2.37 2.69 2.84
Debt Service Coverage Ratio
 1.05 1.06 1.21 0.83 0.18
Interest Coverage Ratio
 8.90 3.89 2.04 1.84 1.64
Debt to Market Cap
 0.07 0.11 0.17 0.15 3.09
Interest Debt Per Share
 0.18 0.18 0.21 0.21 1.80
Net Debt to EBITDA
 1.80 1.80 2.75 2.46 3.36
Profitability Margins
Gross Profit Margin
47.05%46.01%44.82%45.54%41.93%
EBIT Margin
11.44%11.44%10.75%10.83%9.98%
EBITDA Margin
19.78%19.77%19.40%19.10%14.35%
Operating Profit Margin
27.03%11.44%8.04%8.21%6.89%
Pretax Profit Margin
11.99%11.99%6.81%6.38%5.78%
Net Profit Margin
9.53%9.57%16.96%3.67%2.14%
Continuous Operations Profit Margin
8.07%8.07%16.36%3.87%2.43%
Net Income Per EBT
79.45%79.83%249.22%57.62%36.95%
EBT Per EBIT
44.35%104.79%84.66%77.66%83.90%
Return on Assets (ROA)
4.56%4.58%7.15%1.63%0.73%
Return on Equity (ROE)
10.60%10.62%16.95%4.38%2.07%
Return on Capital Employed (ROCE)
19.51%8.26%4.92%5.29%3.92%
Return on Invested Capital (ROIC)
12.08%5.11%4.34%2.93%1.25%
Return on Tangible Assets
7.29%7.33%11.82%2.66%1.22%
Earnings Yield
2.23%3.65%6.71%1.40%10.09%
Efficiency Ratios
Receivables Turnover
 2.76 2.77 3.28 2.35 2.53
Payables Turnover
 3.40 3.47 3.51 2.79 2.92
Inventory Turnover
 1.43 1.46 1.41 1.87 2.08
Fixed Asset Turnover
 2.85 2.85 2.48 2.61 2.29
Asset Turnover
 0.48 0.48 0.42 0.44 0.34
Working Capital Turnover Ratio
 6.45 8.29 6.73 10.49 30.17
Cash Conversion Cycle
 280.19 277.30 266.61 219.70 194.71
Days of Sales Outstanding
 132.02 132.01 111.25 155.50 144.19
Days of Inventory Outstanding
 255.57 250.61 259.32 195.21 175.51
Days of Payables Outstanding
 107.40 105.32 103.97 131.02 124.99
Operating Cycle
 387.59 382.62 370.57 350.71 319.70
Cash Flow Ratios
Operating Cash Flow Per Share
 0.04 0.04 0.03 <0.01 0.16
Free Cash Flow Per Share
 0.01 0.01 -0.03 -0.02 -1.50
CapEx Per Share
 0.03 0.03 0.06 0.02 1.65
Free Cash Flow to Operating Cash Flow
 0.31 0.31 -1.01 -6.64 -9.58
Dividend Paid and CapEx Coverage Ratio
 0.84 0.84 0.50 0.13 0.09
Capital Expenditure Coverage Ratio
 1.46 1.46 0.50 0.13 0.09
Operating Cash Flow Coverage Ratio
 0.24 0.24 0.14 0.02 0.09
Operating Cash Flow to Sales Ratio
 0.11 0.11 0.09 0.01 0.09
Free Cash Flow Yield
0.78%1.28%-3.62%-2.68%-390.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 44.51 27.40 14.89 71.42 9.91
Price-to-Sales (P/S) Ratio
 4.31 2.62 2.53 2.62 0.21
Price-to-Book (P/B) Ratio
 4.73 2.91 2.53 3.13 0.21
Price-to-Free Cash Flow (P/FCF) Ratio
 128.37 78.08 -27.59 -37.34 -0.26
Price-to-Operating Cash Flow Ratio
 39.70 24.42 27.89 247.91 2.45
Price-to-Earnings Growth (PEG) Ratio
 -1.33 -0.81 0.04 -1.00 -0.17
Price-to-Fair Value
 4.73 2.91 2.53 3.13 0.21
Enterprise Value Multiple
 23.60 15.06 15.77 16.20 4.84
Enterprise Value
 292.09M 186.39M 162.00M 157.56M 27.09M
EV to EBITDA
 23.60 15.06 15.77 16.20 4.84
EV to Sales
 4.67 2.98 3.06 3.09 0.69
EV to Free Cash Flow
 138.96 88.67 -33.42 -44.02 -0.84
EV to Operating Cash Flow
 43.46 27.73 33.78 292.32 8.04
Tangible Book Value Per Share
 0.04 0.04 0.02 -0.01 -0.27
Shareholders’ Equity Per Share
 0.33 0.33 0.31 0.25 1.87
Tax and Other Ratios
Effective Tax Rate
 0.33 0.33 -1.40 0.39 0.58
Revenue Per Share
 0.37 0.37 0.31 0.30 1.81
Net Income Per Share
 0.04 0.04 0.05 0.01 0.04
Tax Burden
 0.79 0.80 2.49 0.58 0.37
Interest Burden
 1.05 1.05 0.63 0.59 0.58
Research & Development to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
 0.35 0.18 0.18 0.05 0.06
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.33 1.33 0.55 0.27 1.57
Currency in EUR